CARMAT
CARMAT is a medtech company, offering biocompatible, auto-regulated total artificial hearts, including right and left ventricles designed to be as close as possible to the human heart. It is designed for patients suffering from chronic terminal heart failure reaching class IV on the New York Heart Association classification; or acute terminal heart failure following a massive myocardial infarction. CARMAT’s aim is to offer a reliable new treatment and innovative therapeutic solution to heart failure patients, who are not eligible for a transplant and who have exhausted every drug-related possibility. It was launched in 2008 by [Philippe Pouletty](https://www.crunchbase.com/person/philippe-pouletty) and is based in Vélizy-villacoublay.
CARMAT
Industry:
Artificial Intelligence Health Care Information Technology
Founded:
2008-01-01
Address:
Vélizy-villacoublay, Ile-de-France, France
Country:
France
Website Url:
http://www.carmatsa.com
Total Employee:
101+
Status:
Active
Contact:
+33139456450
Total Funding:
214 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Content Delivery Network Domain Not Resolving Nginx Sitelinks Search Box Euro
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2009-07-01
Board_member
Board_member
Board_member
Current Employees Featured
Pascale d'Arbonneau Chief Financial Officer @ CARMAT
Chief Financial Officer
Petrus Jansen Chief Medical Officer @ CARMAT
Chief Medical Officer
2009-01-01
Alain Carpentier Scientific Director @ CARMAT
Scientific Director
Marcello Conviti CEO @ CARMAT
CEO
Stephane Piat Chief Executive Officer @ CARMAT
Chief Executive Officer
Philippe Pouletty Co-Founder @ CARMAT
Co-Founder
Lucie Vacirova Clinical Research Coordinator @ CARMAT
Clinical Research Coordinator
2018-01-01
Patrick Coulombier Deputy General Director @ CARMAT
Deputy General Director
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - CARMAT
Truffle Capital
Truffle Capital investment in Funding Round - CARMAT
Official Site Inspections
http://www.carmatsa.com Semrush global rank: 4.41 M Semrush visits lastest month: 2.52 K
- Host name: undef-77-178.c-si.fr
- IP address: 91.151.77.178
- Location: Asnieres-sur-Seine France
- Latitude: 48.9119
- Longitude: 2.2875
- Timezone: Europe/Paris
- Postal: 92600
More informations about "CARMAT"
Home - Carmat :Carmat
Gestion de vos préférences sur les cookies. Carmat SA utilise des cookies pour recueillir des informations sur la façon dont vous utilisez le site Internet www.carmatsa.com.Un cookie est …See details»
Home - Carmat :Carmat
3 days ago press release. January 8th 2025 . CARMAT delivers a solid FY 2024 with 42 implants of its Aeson® artificial heart and anticipates continued strong momentum in 2025See details»
About Carmat - Carmat :Carmat
Nov 21, 2024 26/12/2022. First implant of Aeson® within the framework of the EFICAS clinical study in France. This prospective study will involve a total of 52 patients eligible for a heart transplant in France and will allow CARMAT to …See details»
CARMAT - Crunchbase Company Profile & Funding
CARMAT is a medtech company that develops and manufactures bioprosthetic artificial hearts for the healthcare industry. The company is offering …See details»
Carmat SA - VentureRadar
Website: http://www.carmatsa.com/ Develops and commercializes Aeson, a medical device that replaces ventricles in patients with advanced heart failure, restoring ...See details»
Carmat SA (EPA: ALCAR) Company Profile & Overview - Stock …
Nov 29, 2024 Company profile for Carmat SA (EPA: ALCAR) with a description, list of executives, contact details and other key facts.See details»
Carmat - Devex
Learn more about Carmat's jobs, projects, latest news, contact information and geographical presence. CHRONIC HEART FAILURE IS A PROGRESSIVE DISEASE THAT AFFECTS …See details»
Qui sommes nous - Carmat :Carmat
26/12/2022. 1ère implantation d'Aeson® dans le cadre de l'étude clinique EFICAS en France. Cette étude prospective portera sur 52 patients éligibles à une transplantation en France et permettra à CARMAT de recueillir des données …See details»
Carmat Company Profile 2025: Stock Performance & Earnings
Carmat General Information Description. Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable …See details»
Carmat - Company Profile & Staff Directory - ContactOut
CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart. The Company’s ambition is to make Aeson® the first alternative to a heart transplant, …See details»
Carmat - Overview, News & Similar companies | ZoomInfo.com
Carmat contact info: Phone number: +33 139456450 Website: www.carmatsa.com What does Carmat do? A credible response to end-stage heart failure: CARMAT aims to eventually …See details»
Carmat Company Profile - Office Locations, Competitors, Revenue …
Carmat has 5 employees across 2 locations and €2.8 m in annual revenue in FY 2023. See insights on Carmat including office locations, competitors, revenue, financials, executives, …See details»
Carmat SA - VentureRadar
Carmat SAS is the designer and developer of the world’s most advanced artificial heart. Carmat is an innovative medtech company created and financed... ... Find out ...See details»
carmatsa.com Reviews | check if site is scam or legit| Scamadviser
Why does carmatsa.com have an average to good trust score?. carmatsa.com is very likely not a scam but legit and reliable. Our algorithm gave the review of carmatsa.com a relatively high …See details»
Investors - Carmat :Carmat
Investor Contact CARMAT processes personal data to respond to any investor requests regarding CARMAT SA. The personal data you send us via the contact@carmatsas.com address and …See details»
Carmat - Overview, Competitors and Decision Makers from France …
Sep 19, 2020 Carmatis headquartered in France, Vélizy-Villacoublay - specialized in Medical Device - Find employees, decision makers, competitors and company information. DataLead …See details»
Carmat: A Frankencompany Or The Next Best Hope For Heart …
Jan 6, 2014 Source: carmatsa.com. ... (the French governmental organization that guarantees credits provided to entrepreneurial companies). So far, the company has written down these …See details»
CARMAT Announces a Software Enhancement Which Significantly …
PARIS, December 28, 2023--Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), designer and developer of the world's most advanced total artificial heart, …See details»
Canada Border Services Agency’s Assessment Revenue …
Oct 30, 2024 A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( A locked padlock ) or https:// means you’ve safely …See details»
CARMAT reports its FY 2021 financial results and confirms its 2022 ...
Operating expenses as the Company has strengthened its organization, notably in manufacturing, to prepare for its commercial launch; and by non-recurring expenses of €8.1 million. CARMAT …See details»